The Liechtenstein Financial Market Authority ordered coercive measures against Nucleus Life AG by transferring its insurance portfolio to Quantum Life AG and withdrawing Nucleus Life AG’s licence, citing the need to protect insured persons and the reputation of the Liechtenstein financial market. The action follows findings that Nucleus Life AG and its shareholders no longer met regulatory requirements under the Insurance Supervision Act, which sets specific expectations for insurers and their direct and indirect shareholders. Insurance contracts will continue unchanged and without interruption at Quantum Leben AG, which has taken over the contracts and the funds earmarked for them, with the contractual counterparty as the only change for policyholders. Quantum Leben AG, Vaduz, is licensed and supervised by the FMA and is described as meeting the requirements to assume and administer the portfolio in an orderly manner.
Liechtenstein Financial Market Authority 2026-03-27
Liechtenstein Financial Market Authority transfers Nucleus Life insurance portfolio to Quantum Life and withdraws Nucleus Life licence
The Liechtenstein Financial Market Authority has enforced measures against Nucleus Life AG, transferring its insurance portfolio to Quantum Life AG and revoking its licence to protect insured persons and the market's reputation. This decision follows findings that Nucleus Life AG and its shareholders failed to meet regulatory standards under the Insurance Supervision Act. Insurance contracts will remain unchanged, with Quantum Leben AG assuming administration as the new contractual counterparty.